Skip to main content
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
69.15
-1.55 (-2.19%)
At close: Mar 9, 2026, 4:00 PM EDT
69.15
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:30 PM EDT

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $11.79M in the quarter ending September 30, 2025, a decrease of -51.13%. This brings the company's revenue in the last twelve months to $62.60M, down -32.79% year-over-year. In the year 2024, Nektar Therapeutics had annual revenue of $98.43M with 9.22% growth.

Revenue (ttm)
$62.60M
Revenue Growth
-32.79%
P/S Ratio
30.19
Revenue / Employee
$1,026,230
Employees
61
Market Cap
1.93B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202498.43M8.31M9.22%
Dec 31, 202390.12M-1.93M-2.10%
Dec 31, 202292.06M-9.85M-9.67%
Dec 31, 2021101.91M-51.01M-33.36%
Dec 31, 2020152.92M38.30M33.41%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ultragenyx Pharmaceutical 673.00M
Aurinia Pharmaceuticals 283.06M
Iovance Biotherapeutics 263.50M
Stoke Therapeutics 205.63M
Soleno Therapeutics 190.41M
Syndax Pharmaceuticals 172.35M
Mesoblast 65.38M
Ascentage Pharma Group International 54.52M
Revenue Rankings

NKTR News

More News